LUMC Researcher Receives Dekker Grant for Heart Research
Leiden Researcher Awarded Major Grant to Study Heart Rhythm disorders in Congenital Heart Defects
Leiden, Netherlands – Professor Dr. Monique Jongbloed of Leiden University Medical Center (LUMC) has been awarded a prestigious Dekkerbeurs grant,a significant honor bestowed annually by the Dutch Heart Foundation. This substantial grant, totaling nearly €850,000, will enable Jongbloed to dedicate the next several years to groundbreaking research on heart and vascular diseases in individuals with congenital heart defects.
Jongbloed’s research aims to explore innovative methods for detecting and treating heart rhythm disorders in this vulnerable population. Her work holds the potential to revolutionize the way these conditions are managed, offering hope for improved outcomes and quality of life for patients.
The Dekkerbeurs is named in honor of Dr. E.Dekker, a pioneering figure in Dutch healthcare who spearheaded the development of citizen-led first aid for cardiac arrest. his legacy of innovation and dedication to cardiovascular health continues to inspire researchers like Jongbloed.
groundbreaking Research Offers Hope for Patients with Congenital Heart Defects
Leiden, Netherlands – Professor Dr. Monique Jongbloed of Leiden university Medical Center (LUMC) has been awarded the prestigious Dekkerbeurs grant, a meaningful honour from the Dutch Heart Foundation. The €850,000 grant will fuel Jongbloed’s pioneering research on heart rhythm disorders in individuals with congenital heart defects.
Jongbloed’s research aims to develop innovative methods for detecting and treating these potentially life-threatening conditions.
“This research is crucial as individuals with congenital heart defects are at increased risk of developing heart rhythm disorders,which can significantly impact their quality of life and even be fatal,” says Jongbloed. “My goal is to find new and effective ways to identify these problems early and develop targeted treatments to improve patient outcomes.”
The Dekkerbeurs, named after Dr. E. Dekker, a Dutch pioneer in heart health, recognizes researchers who are pushing the boundaries of cardiovascular medicine. Jongbloed’s work exemplifies Dr. Dekker’s legacy of innovation and dedication to improving cardiovascular health.
Jongbloed’s research holds the potential to revolutionize the way heart rhythm disorders are managed in patients with congenital heart defects, offering hope for a brighter future for these vulnerable individuals.